Lack of physiological suppression of circulating IGFBP-1 in puberty in patients with insulin-dependent diabetes mellitus

European Journal of Endocrinology

Volumn 147, Issue 2, 2002, Pages 235-241

  Riihimaa, Päivi H ^a   Knip, Mikael ^a   Ruokonen, Aimo ^a   Tapanainen, Päivi ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; INSULIN ANTIBODY; LEPTIN; SOMATOMEDIN BINDING PROTEIN 1;

ADOLESCENT; ARTICLE; BLOOD SAMPLING; BODY FAT; CLINICAL FEATURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; JUVENILE DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; OUTPATIENT DEPARTMENT; PEDIATRICS; PRIORITY JOURNAL; SCHOOL CHILD; SEX DIFFERENCE; UNIVERSITY HOSPITAL;

EID: 0036677795     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1470235     Document Type: Article

References (29)

1. Impaired insulin action in puberty: A contributing factor to poor glycaemic control in adolescents with diabetes
2. Puberty decreases insulin sensitivity
3. Insulin resistance of puberty: A defect restricted to peripheral glucose metabolism
4. Insulin-like growth factor binding protein-1 levels in diabetic adolescents and their relationship to metabolic control
5. Abnormal regulation of insulin-like growth factor binding proteins in adolescents with insulin-dependent diabetes
6. Serum leptin levels in children and adolescents with insulin-dependent diabetes mellitus in relation to metabolic control and body mass index
7. Leptin levels in non-obese and obese children and young adults with Type 1 diabetes mellitus
8. High serum leptin levels in children with Type 1 diabetes mellitus: Contribution to age, BMI, pubertal development and metabolic status
9. Elevated leptin levels are associated with excess gains in fat mass in girls, but not boys, with Type 1 diabetes: Longitudinal study during adolescence
10. Clinical significance of insulin antibodies in insulin-treated diabetic patients
11. Metabolic characteristics and urine albumin excretion rate in relation to pubertal maturation in type 1 diabetes
12. The development of the reproductive system
13. Clinical measurement of testes in boys and men
14. A novel format for a growth chart
15. Measurement, recording, and assessment of skinfold thickness in childhood and adolescence: Report of a small meeting
16. Total body fat and skinfold thickness in children
17. Body fat in adult man
18. Pregnancy induces nonimmunoglobulin insulin-binding activity in both maternal and cord blood serum
19. A novel micro-assay for insulin autoantibodies
20. Radioimmunoassay of leptin in human plasma
21. Relationship between the pubertal fall in sex hormone binding globulin and insulin-like growth factor binding protein-I. A synchronized approach to pubertal development?
22. Altered relation between circulating levels of insulin-like growth factor-binding protein-1 and insulin in growth hormone-deficient patients and insulin-dependent diabetic patients compared to that in healthy subjects
23. Insulin-like growth factor I, its binding proteins 1 and 3, and growth hormone-binding protein in children and adolescents with insulin-dependent diabetes mellitus: Clinical implications
24. Role of IGF binding protein-1 in the dawn phenomenon and glycemic control in children and adolescents with IDDM
25. Serum leptin concentrations in relation to pubertal development
26. Serum leptin levels in normal children: Relationship to age, gender, body mass index, pituitary-gonadal hormones, and pubertal stage
27. Leptin synthesis is resistant to acute effects of insulin in insulin-dependent diabetes mellitus patients
28. The growth hormone independent insulin-like growth factor-1 binding protein BP-28 is associated with serum insulin-like growth factor-1 inhibitory bioactivity in adolescent insulin-dependent diabetics
29. Growth hormone insulin-like growth factor I axis in insulin-dependent diabetes mellitus